Layoffs resulted at the plant "to ensure capacity is effectively utilized based on projected product demands," the company ...

We recently compiled a list of the 8 Good Stocks To Buy Right Now. In this article, we are going to take a look at where ...

Here's a recap of the week’s most important stories.

Following the FDA approval, PFE's Hympavzi becomes the first hemophilia medicine approved in the United States to be ...

Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...

Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...

The once-weekly injectable joins one-shot haemophilia B gene therapy Beqvez (fidanacogene elaparvovec) in Pfizer’s portfolio, ...

Pfizer (NYSE: PFE) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over ...

AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...

PFE obtains $1 billion from activist investor Starboard Value. Stock gains on hopes of a plausible turnaround of the ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

Privately held Triana focuses on building a molecular glue pipeline developed through its platform, which is designed to identify small molecules that induce protein:protein interactions between ...